SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-007606
Filing Date
2022-02-28
Accepted
2022-02-28 16:06:11
Documents
98
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apls-10k_20211231.htm   iXBRL 10-K 4410883
2 EX-4.4 apls-ex44_16.htm EX-4.4 15674
3 EX-10.10 apls-ex1010_257.htm EX-10.10 22943
4 EX-10.29 apls-ex1029_255.htm EX-10.29 25349
5 EX-10.30 apls-ex1030_256.htm EX-10.30 45681
6 EX-21.1 apls-ex211_11.htm EX-21.1 13326
7 EX-23.1 apls-ex231_9.htm EX-23.1 2541
8 EX-31.1 apls-ex311_14.htm EX-31.1 21310
9 EX-31.2 apls-ex312_15.htm EX-31.2 21411
10 EX-32.1 apls-ex321_10.htm EX-32.1 9712
11 EX-32.2 apls-ex322_12.htm EX-32.2 9599
12 GRAPHIC g3qav3nknoio000001.jpg GRAPHIC 96699
13 GRAPHIC gg0b4wbfswa2000001.jpg GRAPHIC 39568
14 GRAPHIC g3qav3nknoio000002.jpg GRAPHIC 530018
15 GRAPHIC gfsxoudqkq03000001.jpg GRAPHIC 39568
  Complete submission text file 0001564590-22-007606.txt   16138067

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA apls-20211231.xsd EX-101.SCH 90386
17 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20211231_cal.xml EX-101.CAL 84623
18 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20211231_def.xml EX-101.DEF 291545
19 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20211231_lab.xml EX-101.LAB 680180
20 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20211231_pre.xml EX-101.PRE 527454
92 EXTRACTED XBRL INSTANCE DOCUMENT apls-10k_20211231_htm.xml XML 2529603
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38276 | Film No.: 22689333
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences